Antinociceptive effects of two deltorphins analogs in the tail-immersion test in rats

Peptides

Volumn 39, Issue 1, 2013, Pages 103-110

  Kotlinska, J H ^a   Gibula Bruzda, E ^a   Witkowska, E ^b   Chung, N N ^c   Schiller, P W ^c   Izdebski, J ^b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b UNIVERSITY OF WARSAW   (Poland)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Deltorphins analogs; Morphine; Nociception; Rats; Tail immersion test; Tolerance

Indexed keywords

BETA FUNALTREXAMINE; CYCLO (N DELTA, N DELTA CARBONYL DEXTRI ORN 2, ORN4) DELTORPHIN; DELTA OPIATE RECEPTOR; DELTORPHIN; DELTORPHIN II N (UREIDOETHYL) AMIDE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; MORPHINE; NALTRINDOLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CROSS TOLERANCE; DRUG POTENCY; DRUG POTENTIATION; DRUG TOLERANCE; IMMERSION; MALE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; THERMAL STIMULATION;

ANALGESICS, OPIOID; ANIMALS; DRUG SYNERGISM; DRUG TOLERANCE; MALE; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; NOCICEPTION; OLIGOPEPTIDES; PAIN MEASUREMENT; RATS; RATS, WISTAR; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA;

RATTUS;

EID: 84871575197     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2012.11.008     Document Type: Article

References (42)

1. Y. Audigier, H. Mazarguil, R. Gout, and J. Cros Structure-activity relationships of enkephalin analogs at opiate and enkephalin receptors: correlation with analgesia Eur J Pharmacol 63 1980 35 46
2. E.J. Bilsky, S.N. Calderon, T. Wang, R.N. Bernstein, P. Davis, and V.J. Hruby SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist J Pharmacol Exp Ther 273 1995 359 366
3. E.J. Bilsky, R.D. Egleton, S.A. Mitchell, M.M. Palian, P. Davis, and J.D. Huber Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability J Med Chem 43 2000 2586 2590
4. J. Brainin-Mattos, N.D. Smith, S. Malkmus, Y. Rew, M. Goodman, and J. Taulane Cancer-related bone pain is attenuated by a systemically available delta-opioid receptor agonist Pain 122 2006 174 181
5. P. Chaillet, A. Coulaud, J.M. Zajac, M.C. Fournie-Zaluski, J. Costentin, and B.P. Roques The mu rather than the delta subtype of opioid receptors appears to be involved in enkephalin-induced analgesia Eur J Pharmacol 101 1984 83 90
6. M. Ciszewska, M. Kwasiborska, M. Nowakowski, M. Oleszczuk, J. Wójcik, and N.N. Chung N-(ureidoethyl)amides of cyclic enkephalin analogs J Peptide Sci 15 2009 312 318
7. E.E. Codd, J.R. Carson, R.W. Colburn, D.J. Stone, C.R. Van Besien, and P.R. Wade JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3- carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependence J Pharmacol Exp Ther 329 2009 241 251
8. N. Dietis, D.J. Rowbotham, and D.G. Lambert Opioid receptor subtypes: fact or artifact Br J Anaesth. 107 2011 8 18
9. G. Dondio, S. Ronzoni, C. Farina, D. Graziani, C. Parini, and P. Petrillo Selective delta opioid receptor agonists for inflammatory and neuropathic pain Farmaco 56 2001 117 119
10. V. Erspamer, P. Melchiorri, G. Falconieri-Erspamer, L. Negri, R. Corsi, and C. Severini Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites Proc Natl Acad Sci USA 86 1989 5188 5192
11. G.L. Fraser, G.A. Gaudreau, P.B. Clarke, D.P. Ménard, and M.N. Perkins Antihyperalgesic effects of delta opioid agonists in a rat model of chronic inflammation Br J Pharmacol 129 2000 1668 1672
12. M. Glajchen Chronic pain: treatment barriers and strategies for clinical practice J Am Board Fam Pract 14 2001 211 218
13. I. Gomes, B.A. Jordan, A. Gupta, N. Trapaidze, V. Nagy, and L.A. Devi Heterodimerization of mu and delta opioid receptors: a role in opiate synergy J Neurosci 20 2000 RC110
14. A.G. Hayes, M. Skingle, and M.B. Tyers Effect of beta-funaltrexamine on opioid side-effects produced by morphine and U-50, 488H J Pharm Pharmacol 37 1985 841 843
15. S.V. Holdridge, and C.M. Cahill Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain Eur J Pain 11 2007 685 693
16. Y. Hosohata, T.W. Vanderah, T.H. Burkey, M.H. Ossipov, C.J. Kovelowski, and I. Sora delta-Opioid receptor agonists produce antinociception and [35S]GTPgammaS binding in mu receptor knockout mice Eur J Pharmacol 388 2000 241 248
17. C.E. Inturrisi Clinical pharmacology of opioids for pain Clin J Pain 18 2002 S3 S13
18. P.A. Janssen, C.J. Niemegeers, and J.G. Dony The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawal reflex in rats Arzneimittelforschung 13 1963 502 507
19. Q. Jiang, H.I. Mosberg, and F. Porreca Selective modulation of morphine antinociception, but not development of tolerance, by delta receptor agonists Eur J Pharmacol 186 1990 137 141
20. N. Kabli, and C.M. Cahill Anti-allodynic effects of peripheral delta opioid receptors in neuropathic pain Pain 127 2007 84 93
21. J.H. Kotlinska, E. Gibula-Bruzda, A. Pachuta, D. Kunce, E. Witkowska, and N.N. Chung Influence of new deltorphins analogs on reinstatement of cocaine-induced conditioned place preference in rats Behav Pharmacol 21 2010 638 648
22. J. Kotlinska Are glycineB sites involved in the development of morphine tolerance Pol J Pharmacol 56 2004 51 57
23. G. Kreil, D. Barra, M. Simmaco, V. Erspamer, G.F. Erspamer, and L. Negri Deltorphin, a novel amphibian skin peptide with high selectivity and affinity for delta opioid receptors Eur J Pharmacol 162 1989 123 128
24. L.H. Lazarus, S.D. Bryant, S. Salvadori, M. Attila, and L. Sargent Jones Opioid infidelity: novel opioid peptides with dual high affinity for delta- and mu-receptors Trends Neurosci 19 1996 31 35
25. N.M. Lee, L. Leybin, J.K. Chang, and H.H. Loh Opiate and peptide interaction: effect of enkephalins on morphine analgesia Eur J Pharmacol 68 1980 181 185
26. B.A. Levac, B.F. O'Dowd, and S.R. George Oligomerization of opioid receptors: generation of novel signaling units Curr Opin Pharmacol 2 2002 76 81
27. J.J. Lowery, T.J. Raymond, D. Giuvelis, J.M. Bidlack, R. Polt, and E.J. Bilsky In vivo characterization of MMP-2200, a mixed δ/μ opioid agonist, in mice J Pharmacol Exp Ther 336 2011 767 778
28. E. McNicol, N. Horowicz-Mehler, R.A. Fisk, K. Bennett, M. Gialeli-Goudas, and P.W. Chew Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review J Pain 4 2003 231 256
29. A. Morinville, C.M. Cahill, M.J. Esdaile, H. Aibak, B. Collier, and B.L. Kieffer Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice J Neurosci 23 2003 4888 4898
30. V. Otis, P. Sarret, and L. Gendron Spinal activation of delta opioid receptors alleviates cancer-related bone pain Neuroscience 183 2011 221 229
31. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates 5th ed. 2005 Elsevier Academic Press San Diego p. 1-367
32. P. Petrillo, O. Angelici, S. Bingham, G. Ficalora, M. Garnier, and P.F. Zaratin Evidence for a selective role of the δ-opioid agonist [8R-(4bS*,8aα,8aβ,12bβ)]7,10-dimethyl-1-methoxy-11-(2- methylpropyl)oxycarbonyl 5,6,7,8,12,12b-hexahydro-(9H)-4,8-methanobenzofuro[3,2- e]pyrrolo[2,3-g]isoquinoline hydrochloride (SB-235863) in blocking hyperalgesia associated with inflammatory and neuropathic pain responses J Pharmacol Exp Ther 307 2003 1079 1089
33. F. Porreca, J.S. Heyman, H.I. Mosberg, J.R. Omnaas, and J.L. Vaught Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [d-Pen2, d-Pen5]enkephalin in the mouse J Pharmacol Exp Ther 241 1987 393 400
34. P.S. Portoghese, M. Sultana, and A.E. Takemori Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist Eur J Pharmacol 146 1988 185 186
35. I. Power An update on analgesics Br J Anaesth 107 2011 19 24
36. R.S. Rapaka, and F. Porreca Development of delta opioid peptides as nonaddicting analgesics Pharm Res 8 1991 1 8
37. G. Scherrer, N. Imamachi, Y.Q. Cao, C. Contet, F. Mennicken, and D. O'Donnell Dissociation of the opioid receptor mechanisms that control mechanical and heat pain Cell 137 2009 148 159
38. R. Schmidt, D. Menard, C. Mrestani-Klaus, N.N. Chung, C. Lemieux, and P.W. Schiller Structural modifications of the N-terminal tetrapeptide segment of [d-Ala2]deltorphin I: effects on opioid receptor affinities and activities in vitro and on antinociceptive potency Peptides 18 1997 1615 1621
39. C. Stein, M. Schäfer, and H. Machelska Why is morphine not the ultimate analgesic and what can be done to improve it J Pain 1 2000 51 56
40. A.E. Takemori, B.Y. Ho, J.S. Naeseth, and P.S. Portoghese Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays J Pharmacol Exp Ther 246 1988 255 258
41. Y.H. Wang, J.F. Sun, Y.M. Tao, Z.Q. Chi, and J.G. Liu The role of kappa-opioid receptor activation in mediating antinociception and addiction Acta Pharmacol Sin 31 2010 1065 1070
42. A. Zieleniak, S. Rodziewicz-Motowidło, Ł. Rusak, N.N. Chung, C. Czaplewski, and E. Witkowska Deltorphin analogs restricted via a urea bridge: structure and opioid activity J Peptide Sci 14 2008 830 837